<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02537106</url>
  </required_header>
  <id_info>
    <org_study_id>201508-S23P</org_study_id>
    <nct_id>NCT02537106</nct_id>
  </id_info>
  <brief_title>A Comparison of the Effect of 1.5 Versus 3% NaCl on Brain Relaxation and Microcirculation</brief_title>
  <official_title>A Comparison of the Effect of 1.5% Versus 3% NaCl on Brain Relaxation and Microcirculation During the Supratentorial Brain Tumor Surgery, and Natremia and Ssmolarity in Postoperative Period</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital Hradec Kralove</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital Hradec Kralove</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Hyperosmotic solutions of 1.5% and 3% NaCl are equally effective for brain relaxation and
      microcirculation during brain surgery. The effect of 1.5% NaCl on postoperative natremia and
      natriuresis is less pronounced.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      All the patients meeting the study criteria will be randomized into two groups. After
      standardized induction to general anesthesia all patients will be given the infusion of
      hyperosmotic NaCl 5 ml/kg/BW during 30 min, group A 1.5% NaCl, group B 3% NaCl.
      Corticosteroids will be administered as usually. After dura opening the brain relaxation
      score will be assessed by surgeon (1 = completely relaxed, 2 = satisfactorily relaxed, 3 =
      firm brain, 4 = bulging brain), and the first measurement of the brain microcirculation
      provided by use of SDF probe in the area of the healthy brain, and of perifocal oedema. Both
      sites of investigation will be marked for the second measurement, which will be done after
      the end of tumor resection. Laboratory examinations: natremia preoperatively, natremia and
      osmolarity peroperatively 1 hour after NaCl infusion and at the end of surgery. Concentration
      of natrium will be examined in CSF after dura opening. Anesthesia management will be
      according to the standardised protocol, the patients will be awaken and extubated after the
      end of the procedure at the operating theatre.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>September 2015</start_date>
  <completion_date type="Anticipated">December 2018</completion_date>
  <primary_completion_date type="Anticipated">December 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Changes in brain microcirculation</measure>
    <time_frame>from dura opening till the end of tumor resection</time_frame>
    <description>measurement by SDF probe MicroVision</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Changes in natremia</measure>
    <time_frame>1 hour after hypertonic NaCl infusion</time_frame>
    <description>mmol/l</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in natremia</measure>
    <time_frame>5 min after the end of surgery</time_frame>
    <description>mmol/l</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in osmolarity</measure>
    <time_frame>1 hour after hypertonic NaCl infusion</time_frame>
    <description>mosm/l</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in osmolarity</measure>
    <time_frame>5 min after the end of surgery</time_frame>
    <description>mosm/l</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Concentration of natrium in cerebrospinal fluid</measure>
    <time_frame>after dura opening</time_frame>
    <description>mmol/l</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Changes in diuresis</measure>
    <time_frame>at the time of extubation</time_frame>
    <description>ml/hour</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Brain Tumors</condition>
  <arm_group>
    <arm_group_label>1.5% NaCl</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>After standardized induction to general anesthesia group A patients will be given the infusion of hyperosmotic 1.5% NaCl 5 ml/kg/BW during 15 min.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>3% NaCl</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>After standardized induction to general anesthesia group B patients will be given the infusion of hyperosmotic 3% NaCl 5 ml/kg/BW during 15 min.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>1.5% NaCl</intervention_name>
    <description>After the infusion of 1.5% NaCl and dura opening the microcirculation and the brain relaxation score will be measured in the area of healthy brain and perifocal oedema sites. Microcirculation measurement will be repeated at the same sites after tumor resection.</description>
    <arm_group_label>1.5% NaCl</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>3% NaCl</intervention_name>
    <description>After the infusion of 3% NaCl and dura opening the microcirculation and the brain relaxation score will be measured in the area of healthy brain and perifocal oedema sites. Microcirculation measurement will be repeated at the same sites after tumor resection.</description>
    <arm_group_label>3% NaCl</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  peripheral supratentorial brain tumors or metastasis

          -  indication for osmotherapy

          -  ASA status I-III

        Exclusion Criteria:

          -  reoperation

          -  osmotherapy prior to surgery

          -  preoperative natremia less than 135 mmol/l and more than 140 mmol/l

          -  GCS less than 14

          -  obstructive hydrocephalus
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Vlasta Dostalova, MD.</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital Hradec Kralove</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Tomas Suchy, MD.</last_name>
    <phone>+420495832187</phone>
    <email>tomas.suchy@fnhk.cz</email>
  </overall_contact>
  <location>
    <facility>
      <name>University Hospital Hradec Kralove</name>
      <address>
        <city>Hradec Kralove</city>
        <zip>50005</zip>
        <country>Czechia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Suchy Tomas, MD</last_name>
      <phone>00420495833218</phone>
      <email>suchy@fnhk.cz</email>
    </contact>
    <contact_backup>
      <last_name>Dostal Pavel, MD, PhD</last_name>
      <phone>00420495832828</phone>
      <email>pavel.dostal@fnhk.cz</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Czechia</country>
  </location_countries>
  <removed_countries>
    <country>Czech Republic</country>
  </removed_countries>
  <verification_date>October 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 27, 2015</study_first_submitted>
  <study_first_submitted_qc>August 31, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 1, 2015</study_first_posted>
  <last_update_submitted>October 26, 2017</last_update_submitted>
  <last_update_submitted_qc>October 26, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">October 27, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University Hospital Hradec Kralove</investigator_affiliation>
    <investigator_full_name>Dostalova Vlasta, MD, PhD</investigator_full_name>
    <investigator_title>Dostalova Vlasta, MD, PhD</investigator_title>
  </responsible_party>
  <keyword>Brain Tumors</keyword>
  <keyword>Microcirculation</keyword>
  <keyword>Osmotherapy</keyword>
  <keyword>Hypertonic NaCl</keyword>
  <keyword>Natremia</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Brain Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

